Renaissance Technologies (RenTech)'s VRCA Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 21,769 shares of Verrica Pharmaceuticals Inc. (VRCA) worth $133,226, representing 0.00% of the portfolio. First purchased in 2014-Q1, this long-term strategic position has been held for 39 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in VRCA, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2021, adding 55,972 shares. Largest reduction occurred in Q2 2021, reducing 63,042 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Verrica Pharmaceuticals (VRCA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Verrica Pharmaceuticals (VRCA) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | -10,591 | Reduce 32.73% | 21,769 | $6.12 |
| Q1 2026 | +5,960 | Add 22.58% | 32,360 | $5.29 |
| Q4 2025 | -2,791 | Reduce 9.56% | 26,400 | $8.31 |
| Q3 2025 | +20,471 | Add 234.76% | 29,191 | $4.31 |
| Q2 2025 | +8,720 | New Buy | 8,720 | $5.30 |
| Q1 2025 | -23,330 | Sold Out | 0 | $0.00 |
| Q4 2024 | +8,534 | Add 57.68% | 23,330 | $7.00 |
| Q3 2024 | +10,244 | Add 225.04% | 14,796 | $14.50 |
| Q2 2024 | +4,552 | New Buy | 4,552 | $72.91 |
| Q4 2023 | -6,810 | Sold Out | 0 | $0.00 |
| Q3 2023 | -9,120 | Reduce 57.25% | 6,810 | $38.91 |
| Q2 2023 | +10,280 | Add 181.95% | 15,930 | $0.06 |
| Q1 2023 | -9,987 | Reduce 63.87% | 5,650 | $0.06 |
| Q4 2022 | -7,393 | Reduce 32.10% | 15,637 | $0.03 |
| Q4 2022 | -15,280 | Reduce 66.35% | 7,750 | $0.06 |
| Q3 2022 | +18,240 | Add 380.79% | 23,030 | $29.18 |
| Q2 2022 | +4,790 | New Buy | 4,790 | $19.21 |
| Q4 2021 | -27,216 | Sold Out | 0 | $0.00 |
| Q3 2021 | +18,076 | Add 197.77% | 27,216 | $52.40 |
| Q2 2021 | -63,042 | Reduce 87.34% | 9,140 | $132.28 |
| Q1 2021 | +55,972 | Add 345.29% | 72,182 | $14.10 |
| Q4 2020 | +16,210 | New Buy | 16,210 | $7.09 |
| Q3 2020 | -13,986 | Sold Out | 0 | $0.00 |
| Q2 2020 | +6,278 | Add 81.45% | 13,986 | $7.15 |
| Q1 2020 | +6,318 | Add 454.53% | 7,708 | $5.97 |
| Q4 2019 | -261 | Reduce 15.81% | 1,390 | $158.99 |
| Q4 2019 | +6,740 | Add 408.24% | 8,391 | $15.37 |
| Q3 2019 | -7,015 | Reduce 80.95% | 1,651 | $11.51 |
| Q2 2019 | -5,024 | Reduce 36.70% | 8,666 | $15.12 |
| Q1 2019 | -4,433 | Reduce 24.46% | 13,690 | $16.22 |
| Q4 2018 | -269 | Reduce 1.46% | 18,123 | $10.21 |
| Q3 2018 | +10,439 | Add 131.26% | 18,392 | $17.13 |
| Q2 2018 | +343 | Add 4.51% | 7,953 | $10.56 |
| Q1 2018 | +1,150 | Add 17.80% | 7,610 | $11.17 |
| Q4 2017 | +5,360 | Add 487.27% | 6,460 | $9.44 |
| Q3 2017 | -250 | Reduce 18.52% | 1,100 | $7.27 |
| Q2 2017 | +1,350 | New Buy | 1,350 | $10.37 |
| Q1 2017 | -3,440 | Sold Out | 0 | $0.00 |
| Q4 2016 | +3,440 | New Buy | 3,440 | $13.08 |
| Q2 2014 | -1,180 | Sold Out | 0 | $0.00 |
| Q1 2014 | +1,180 | New Buy | 1,180 | $64.41 |
Renaissance Technologies (RenTech)'s Verrica Pharmaceuticals Investment FAQs
Renaissance Technologies (RenTech) first purchased Verrica Pharmaceuticals Inc. (VRCA) in Q1 2014, acquiring 1,180 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Verrica Pharmaceuticals Inc. (VRCA) for 39 quarters since Q1 2014.
Renaissance Technologies (RenTech)'s largest addition to Verrica Pharmaceuticals Inc. (VRCA) was in Q1 2021, adding 72,182 shares worth $1.02 M.
According to the latest 13F filing for Q2 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 21,769 shares of Verrica Pharmaceuticals Inc. (VRCA), valued at approximately $133,226.
As of the Q2 2026 filing, Verrica Pharmaceuticals Inc. (VRCA) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Verrica Pharmaceuticals Inc. (VRCA) was 72,182 shares, as reported at the end of Q1 2021.